Browse Studies — Arctuva

Phase 1

A First-in-Human, Phase 1/2 Trial to Assess the Safety, Tolerability and Preliminary Efficacy of Sofetabart Mipitecan (LY4170156), an Antibody-Drug Conjugate Targeting Folate Receptor α-Expressing Tumor Cells, in Participants With Selected Advanced Solid Tumors

The purpose of this study is to find out whether the study drug, Sofetabart Mipitecan (LY4170156), is safe, tolerable and effective in participants with advanc…

Ovarian NeoplasmsEndometrial NeoplasmsUterine Cervical Neoplasms+4 more

Estimated

~$10 – $7,500

Eli Lilly and CompanyNCT06400472

Phase 1

A Phase 1 Study of Sigvotatug Vedotin in Advanced Solid Tumors

This trial will look at a drug called sigvotatug vedotin (SGN-B6A) alone and with pembrolizumab, with or without chemotherapy, to find out whether it is safe f…

Carcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckHER2 Negative Breast Neoplasms+9 more

Estimated

~$10 – $8,750

Seagen, a wholly owned subsidiary of PfizerNCT04389632

Observational

Human Papillomavirus Self-Sampling Options to Promote Equity (HOPE)

This study is testing a new way to help people who are unhoused get screened for cervical cancer. Cervical cancer can often be prevented if it is found early. …

Uterine Cervical NeoplasmsHPV TestingPap Smear

Estimated

~$10 – $6,250

University of ArizonaNCT07214506

Observational

Enhancing the Effectiveness of Community Health Workers to Reduce Cervical Cancer Disparities in African American Women

The goal of this clinical trial is to test whether an interactive, video-based patient navigation program can improve cervical cancer screening among African A…

Uterine Cervical Neoplasms

Estimated

~$10 – $8,750

ISA Associates, Inc.NCT07011836